Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Non-immune factors play a significant role in alopecia areata.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

The project created a standardized system for classifying skin lesions in lab rats and mice.

Markers help differentiate between apocrine and eccrine sweat glands to identify sweat gland tumors.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

HPV 60 may cause cysts and warts on the face, not just hands and feet.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Early identification of lupus through skin signs and blood tests is crucial in India.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Transplant patients often get skin problems, with treatments varying by condition.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Three white adults had a rare scalp condition with increased fat and sometimes hair loss, suggesting it's not limited to black women and might be more widespread.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Alopecia areata involves immune response and gene changes affecting hair loss.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The model and estimator can predict drug exposure in kidney transplant patients well.